Translational Development Acquisition

TDAC · NASDAQ

$10.81+$0.00 (+0.00%)TodayMarket closed · Oct 23, 7:32 PM ET

Prev close $10.81

Latest news

Press releaseAug 23, 3:00 PM ETPRNewswire
$HAREHOLDER ALERT: The M&A Class Action Firm Announce the Investigation of the Merger - WEAV, BRBS, TDAC and UHG
Press releaseAug 19, 1:19 PM ETBusiness Wire
Translational Development Investor Alert: Kahn Swick & Foti, LLC Investigates Translational Development Acquisition Corp. - TDAC
Press releaseJul 6, 9:51 AM ETPRNewswire
TDAC Announces ProLogium's Filing of F-4 As Continuing Momentum Towards Merger
Press releaseJun 22, 7:05 AM ETPRNewswire
TDAC Announces Very Successful Share Redemption Results in Connection with Extension Vote
Press releaseMay 27, 7:00 AM ETGlobe Newswire
ProLogium, a Next Generation Solid-State Battery Developer with 10+ Years of Proven Commercialization, to List on the Nasdaq through a Merger with Translational Development Acquisition Corp.

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.

Latest news

$HAREHOLDER ALERT: The M&A Class Action Firm Announce the Investigation of the Merger - WEAV, BRBS, TDAC and UHG

Translational Development Investor Alert: Kahn Swick & Foti, LLC Investigates Translational Development Acquisition Corp. - TDAC

TDAC Announces ProLogium's Filing of F-4 As Continuing Momentum Towards Merger

TDAC Announces Very Successful Share Redemption Results in Connection with Extension Vote

ProLogium, a Next Generation Solid-State Battery Developer with 10+ Years of Proven Commercialization, to List on the Nasdaq through a Merger with Translational Development Acquisition Corp.